PubMed · 7039712
Bromocriptine and insulin secretion.
Abstract
The dopaminergic drug bromocriptine inhibited the release of insulin from isolated mouse pancreatic islets. The effect was counteracted by haloperidol or pimozide. It is suggested that insulin release may be inhibited through activation of D-2 dopaminergic receptors in the pancreatic beta-cells.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
E E El-Denshary, N A Ismail, E Gagerman, J Sehlin, I B Täljedal. 1982. Bromocriptine and insulin secretion.. https://doi.org/10.1007/bf01116177
Cite the original work for its findings. Save a collection to share your selection of sources.